Cbdmd, inc. (LEVB)
CashFlow / Yearly
Sep'19Sep'18Sep'17Sep'16
Cash flows from operating activities:
Net income (loss)

-51,357

62

-1,386

-3,896

Adjustments to reconcile net income (loss) to net cash used by operating activities:
Stock based compensation

2,458

639

56

11

Restricted stock expense

230

39

156

0

Issuance of stock / warrants for service

289

496

627

0

Impairment on discontinued operations asset

502

0

-

-

Amortization of debt issue costs

-

-

305

43

Depreciation and amortization

289

222

71

44

Debt conversion expense

-

-

446

0

Inventory impairment

0

262

67

0

Impairment on discontinued operations

3,398

0

-

-

Payment in-kind interest

-30

0

-

-

Accounts receivable impairment

-

-

50

0

Loss on sale of property and equipment - discontinued operations

39

69

4

-

(Increase) decrease on contingent liability

32,461

0

-

-

Realized and unrealized loss of marketable securities

2,439

0

175

0

Intangible impairment

436

240

0

-

Loss on sale of property and equipment

-

-

-

0

Common stock issued as charitable contribution

-

-

17

225

Non-cash consideration received for services

470

3,404

1,932

0

Changes in operating assets and liabilities:
Accounts receivable

60

-499

-27

-

Accounts receivable - related party

-462

-492

-712

0

Other accounts receivable

2

-1,890

-12

-163

Note receivable

0

-459

0

-

Note receivable - related party

156

120

-1

-

Deposits

-761

0

-

-

Merchant reserve

-93

0

-

-

Other accounts receivable - related party

0

236

-36

-

Inventory

-3,123

255

-41

-519

Prepaid inventory

-903

0

-

-

Proceeds from sale of securities

410

0

-

-

Prepaid consulting agreement

0

-200

0

-

Prepaid rent

180

-180

0

-

Prepaid inventory

-

-

-

374

Prepaid expenses and other current assets

-963

-529

58

78

Accounts payable and accrued expenses

2,280

285

-745

785

Accounts payable and accrued expenses - related party

-7

-951

278

0

Interest Payable

-

-

184

110

Deferred revenue/customer deposits

-416

120

41

0

Deferred tax liability

-2,425

-16

25

8

Cash used by operating activities

15,377

-5,573

-2,329

-2,897

Cash flows from investing activities:
Net cash used for merger

916

0

-

-

Purchase of investment other securities

-

-

-200

-

Purchase of other investment securities

0

300

0

-

Purchase of intangible assets

50

360

0

-

Proceeds from sale of investments to a related party

-

-

-

0

Deferred initial public offering costs

-

-

-

0

Purchase of property and equipment

1,198

23

7

127

Cash used by investing activities

-2,133

-683

192

-127

Cash flows from financing activities:
Proceeds from issuance of common stock

19,009

10,927

829

1,984

Note payable - related party

764

0

-

-

Exercise of stock options

-

-

3

0

Deferred issuance costs

-326

-672

-39

-

Debt issuance cost

-

-

200

0

Proceeds from convertible note

-

-

2,125

0

Proceeds from line of credit

-

-

-

1,782

Distribution related party

-

-

-29

0

Repayments of line of credit

-

-

300

1,165

Repayment of note payable shareholder

-

-

-

90

Cash provided by financing activities

17,918

10,254

2,387

2,512

Net increase (decrease) in cash

407

3,998

249

-512

Cash Payments for:
Interest expense

39

0

5

1

Non-cash financial activities:
Equity investment exchange to be issued in the future, included in accounts receivable other

0

160

0

-

Stock received for prior period services, adjusted for other accounts receivable write down prior to receipt - from discontinued operation

1,352

0

-

-

Common stock issued to purchase membership interest a IaM1

-

-

971

-

Common stock issued to purchase membership interest a EE1

-

-

471

-

Common stock issued for financing fees

-

-

-

105

Common stock issued to purchase membership interest - I'M1

-

-

971

0

Common stock issued to purchase membership interest - EE1

-

-

471

0

Non-controlling interest transfer

-

-

950

0

Strike price adjustment on placement agent warrants

-

-

31

0

Common stock issued for warrant exercise

-

-

0

0

Common Stock issued for conversion of Line of Credit

-

-

773

0

Common Stock issued for conversion of Promissory Notes

-

-

2,252

0

Deferred IPO costs acquired via issuance of payables

-

-

362

0

Deferred IPO costs acquired via issuance of stock/warrants

-

-

95

0

Distributions of stock to non-controlling interests

-

-

-223

0

Stock and warrants issued for intangible assets

-

-

379

0

Fixed assets acquired through lease

-

-

14

0

Non-cash proceeds on sale of fixed assets

-

-

7

0

Intellectual property issued via issuance of payables

-

-

945

0

Warrants issued to IPO selling agent

309

171

0

-

Adoption of ASU 2016-01

2,512

0

-

-

Acquisition of property and equipment through a finance lease arrangement

249

0

-

-